Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   PCE(x) 1,963.1175.24-780.09136.79276.87

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is 1,963.11 based on Mar2024 Standalone results.
Year Price to Cash Earnings (PCE)
Mar20241,963.11
Mar202375.24
Mar2022-780.09
Mar2021136.79
Mar2020276.87

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 1963.11
2,509.13
Mar2023 75.24
Positive
Mar2022 -780.09
Negative
Mar2021 136.79
-50.59
Mar2020 276.87 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹125.7 Cr 1.8% -25.3% -50.4% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,550.5 Cr -7.2% -13.9% 83.6% Stock Analytics
KIRI INDUSTRIES ₹3,253.7 Cr -9.3% 2.8% 52.7% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,302.0 Cr -6.7% -1.6% 5.7% Stock Analytics
BODAL CHEMICALS ₹823.3 Cr 2.2% 3.5% -16% Stock Analytics
BHAGERIA INDUSTRIES ₹784.1 Cr -12.2% -0.8% 8.6% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

1.8%

-25.3%

-50.4%

SENSEX

-2.7%

-0.4%

6.4%


You may also like the below Video Courses